Purchase Order 75N92B23P00075
Award Date 8/31/23
Potential Completion Date 12/15/23
Potential Value $23K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94063, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for the development of induced pluripotent stem (iPS) report cell lines expressing HiBiT at specified target genes. The $235,150.00 contract has a 20-24 week period of performance and does not have a set-aside designation. The work will be performed at Synthego's...
- Synthego Corporation has been awarded a firm fixed price purchase order valued at twenty-six thousand three hundred thirty dollars by the National Institute of Dental and Craniofacial Research within the Department of Health and Human Services. Under this contract, Synthego will supply induced pluripotent stem cell clones to the agency as requested in a January 2024 presolicitation notice seeking "Knockin-Small, Cell Clone, iPSC, Synthego Supplied VIAL." Performance will occur at...
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synthego Corporation, a small disadvantaged business, for IPSC engineering services. The firm-fixed-price contract, valued at $1,939,814.20, does not have a set-aside designation. Through this contract, Synthego will provide the NIH with various gene editing products and services, including custom cell clones,...
- The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a firm-fixed-price purchase order contract to Synthego Corporation, a self-certified small disadvantaged business, to create genetically modified cell lines. The $36,300.03 contract requires Synthego to deliver two homozygous and two heterozygous POLR3B cell line clones, as well as two homozygous and two heterozygous POLR3E cell line clones, all derived from...
- This is a $146,665.75 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of goods. The contract was not set aside. Synthego, headquartered in Redwood City, California, is providing genome engineering solutions, including cell line engineering, CRISPR libraries, and other biological...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Purchase Order to Synthego Corporation, a self-certified small disadvantaged business, for the delivery of KNOCKIN-SMALL, CELL CLONE, IMMORTALIZED with a potential value of $12,950.00. This order is part of Synthego's extensive portfolio of federal contracts to provide gene editing products, cell line engineering, and research support services...
- The National Center for Advancing Translational Sciences awarded Synthego Corporation a $21,750 firm fixed price purchase order to identify modifiers of SMCHD1 activity in human cranial placode cells. Under this contract, Synthego will deliver research services to the National Institutes of Health falling under the Department of Health and Human Services larger programs focused on translational science. No subcontractors or set aside designations were indicated. The work will be performed by...
- This is a $12,775 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for Synthego to provide knock-in cell line generation services to support cell biology experiments for Dr. Martina. While this contract is not set aside, Synthego has previously been awarded over 30 prime federal...
- This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
- This federal contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Center for Advancing Translational Sciences to Synthego Corporation, a self-certified small disadvantaged business, for high-throughput screening to identify modulators of the expression of human HIF1 and HIF2. The firm fixed price purchase order, valued at $22,650.00, will support genetic research at Synthego's facilities in Redwood City, California through...